654 related articles for article (PubMed ID: 34717969)
1. Downregulation of hsa-miR-203 in peripheral blood and wound margin tissue by negative pressure wound therapy contributes to wound healing of diabetic foot ulcers.
Liu L; Chen R; Jia Z; Li X; Tang Y; Zhao X; Zhang S; Luo L; Fang Z; Zhang Y; Chen M
Microvasc Res; 2022 Jan; 139():104275. PubMed ID: 34717969
[TBL] [Abstract][Full Text] [Related]
2. Negative pressure wound therapy promotes wound healing of diabetic foot ulcers by up-regulating PRDX2 in wound margin tissue.
Tang Y; Liu L; Jie R; Tang Y; Zhao X; Xu M; Chen M
Sci Rep; 2023 Sep; 13(1):16192. PubMed ID: 37758743
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of miR-204-3p in peripheral blood and wound margin tissue associated with the onset and poor wound healing of diabetic foot ulcers.
Zhao X; Xu M; Tang Y; Xie D; Deng L; Chen M; Wang Y
Int Wound J; 2023 Feb; 20(2):413-429. PubMed ID: 35879811
[TBL] [Abstract][Full Text] [Related]
4. Changes in miroRNA-103 expression in wound margin tissue are related to wound healing of diabetes foot ulcers.
Zhao X; Xu M; Tang Y; Xie D; Wang Y; Chen M
Int Wound J; 2023 Feb; 20(2):467-483. PubMed ID: 35837786
[TBL] [Abstract][Full Text] [Related]
5. miR-23c regulates wound healing by targeting stromal cell-derived factor-1α (SDF-1α/CXCL12) among patients with diabetic foot ulcer.
Amin KN; Umapathy D; Anandharaj A; Ravichandran J; Sasikumar CS; Chandra SKR; Kesavan R; Kunka Mohanram R
Microvasc Res; 2020 Jan; 127():103924. PubMed ID: 31520606
[TBL] [Abstract][Full Text] [Related]
6. Negative pressure wound therapy affects circulating plasma microRNAs in patients with diabetic foot ulceration.
Kapusta P; Konieczny PS; Hohendorff J; Borys S; Totoń-Żurańska J; Kieć-Wilk BM; Wołkow PP; Malecki MT
Diabetes Res Clin Pract; 2020 Jul; 165():108251. PubMed ID: 32531327
[TBL] [Abstract][Full Text] [Related]
7. miR-203 Acts as an Inhibitor for Epithelial-Mesenchymal Transition Process in Diabetic Foot Ulcers via Targeting Interleukin-8.
Yuan L; Sun Y; Xu M; Zeng F; Xiong X
Neuroimmunomodulation; 2019; 26(5):239-249. PubMed ID: 31707396
[TBL] [Abstract][Full Text] [Related]
8. Effects of Negative Pressure Wound Therapy on Levels of Angiopoetin-2 and Other Selected Circulating Signaling Molecules in Patients with Diabetic Foot Ulcer.
Hohendorff J; Drozdz A; Borys S; Ludwig-Slomczynska AH; Kiec-Wilk B; Stepien EL; Malecki MT
J Diabetes Res; 2019; 2019():1756798. PubMed ID: 31781660
[TBL] [Abstract][Full Text] [Related]
9. Expanded negative pressure wound therapy in healing diabetic foot ulcers: a prospective randomised study.
Campitiello F; Mancone M; Corte AD; Guerniero R; Canonico S
J Wound Care; 2021 Feb; 30(2):121-129. PubMed ID: 33573486
[TBL] [Abstract][Full Text] [Related]
10. Proteomics changes after negative pressure wound therapy in diabetic foot ulcers.
Jia Z; Liu L; Zhang S; Zhao X; Luo L; Tang Y; Shen B; Chen M
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608502
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0084443 Is Upregulated in Diabetic Foot Ulcer and Modulates Keratinocyte Migration and Proliferation.
Wang A; Toma MA; Ma J; Li D; Vij M; Chu T; Wang J; Li X; Xu Landén N
Adv Wound Care (New Rochelle); 2020 Apr; 9(4):145-160. PubMed ID: 32117579
[No Abstract] [Full Text] [Related]
12. Upregulation of circ_0080968 in diabetic foot ulcer inhibits wound healing via repressing the migration and promoting proliferation of keratinocytes.
Fu Z; Jiang Z; Liao X; Liu M; Guo G; Wang X; Yang G; Zhou Z; Hu L; Xiong Z
Gene; 2023 Oct; 883():147669. PubMed ID: 37500023
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of miR-24 in peripheral plasma of type 2 diabetes mellitus patients associated with diabetic foot ulcer.
Li X; Tang Y; Jia Z; Zhao X; Chen M
Wound Repair Regen; 2020 Nov; 28(6):728-738. PubMed ID: 32710681
[TBL] [Abstract][Full Text] [Related]
14. The effect of negative pressure wound therapy on the outcome of diabetic foot ulcers: A meta-analysis.
Zhang N; Liu Y; Yan W; Liu F
Int Wound J; 2024 Apr; 21(4):e14886. PubMed ID: 38651532
[TBL] [Abstract][Full Text] [Related]
15. Negative pressure wound therapy use in diabetic foot syndrome-from mechanisms of action to clinical practice.
Borys S; Hohendorff J; Frankfurter C; Kiec-Wilk B; Malecki MT
Eur J Clin Invest; 2019 Apr; 49(4):e13067. PubMed ID: 30600541
[TBL] [Abstract][Full Text] [Related]
16. Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations - short-term efficacy and long-term outcomes.
Borys S; Hohendorff J; Koblik T; Witek P; Ludwig-Slomczynska AH; Frankfurter C; Kiec-Wilk B; Malecki MT
Endocrine; 2018 Dec; 62(3):611-616. PubMed ID: 30099674
[TBL] [Abstract][Full Text] [Related]
17. Negative pressure wound therapy in the treatment of diabetic foot ulcers may be mediated through differential gene expression.
Borys S; Ludwig-Slomczynska AH; Seweryn M; Hohendorff J; Koblik T; Machlowska J; Kiec-Wilk B; Wolkow P; Malecki MT
Acta Diabetol; 2019 Jan; 56(1):115-120. PubMed ID: 30221321
[TBL] [Abstract][Full Text] [Related]
18. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.
Lin CJ; Lan YM; Ou MQ; Ji LQ; Lin SD
J Endocrinol Invest; 2019 Nov; 42(11):1307-1317. PubMed ID: 31079353
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, controlled clinical study on the effectiveness of a single-use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of diabetic ulcers of the lower extremities.
Kirsner RS; Zimnitsky D; Robinson M
Wound Repair Regen; 2021 Nov; 29(6):908-911. PubMed ID: 34525239
[TBL] [Abstract][Full Text] [Related]
20. Autologous fat grafting combined with negative pressure wound therapy in severe diabetic foot ulcer: a case study.
Biyao Z; Gang X; Hai J; Chenwang D; Xuan L
J Wound Care; 2021 Apr; 30(Sup4):S38-S40. PubMed ID: 33856926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
